Margherita Vieri

Aachen, NW, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 31 publications

Glucose transport dependency defines a therapeutic vulnerability in JAK2V617F-driven myeloproliferative neoplasms.

Glucose transport dependency defines a therapeutic vulnerability in JAK2V617F-driven myeloproliferative neoplasms.

Journal: Cell communication and signaling : CCS

Published: February 27, 2026

Allogeneic stem cell transplantation from variant-carrying family donors leads to long-term engraftment in Telomere Biology Disorders.

Allogeneic stem cell transplantation from variant-carrying family donors leads to long-term engraftment in Telomere Biology Disorders.

Journal: Blood cancer journal

Published: May 16, 2025

ZIP10 as a potential therapeutic target in acute myeloid leukaemia.

ZIP10 as a potential therapeutic target in acute myeloid leukaemia.

Journal: British journal of haematology

Published: February 18, 2025

Telomere Length Is Associated With Adverse Atrial Remodeling in Patients With Atrial Fibrillation.

Telomere Length Is Associated With Adverse Atrial Remodeling in Patients With Atrial Fibrillation.

Journal: Journal of the American Heart Association

Published: February 03, 2025

Late-onset telomere biology disorders in adults: clinical insights and treatment outcomes from a retrospective registry cohort.

Late-onset telomere biology disorders in adults: clinical insights and treatment outcomes from a retrospective registry cohort.

Journal: Blood advances

Published: September 04, 2024

Deciphering the complex clonal heterogeneity of polycythemia vera and the response to interferon alfa.

Deciphering the complex clonal heterogeneity of polycythemia vera and the response to interferon alfa.

Journal: Blood advances

Published: January 08, 2024

Cellular aging is accelerated in the malignant clone of myeloproliferative neoplasms.

Cellular aging is accelerated in the malignant clone of myeloproliferative neoplasms.

Journal: Blood cancer journal

Published: August 15, 2023

Telomere biology disorders may manifest as common variable immunodeficiency (CVID).

Telomere biology disorders may manifest as common variable immunodeficiency (CVID).

Journal: Clinical immunology (Orlando, Fla.)

Published: July 17, 2023

Myelofibrosis at diagnosis is associated with the failure of treatment-free remission in CML patients.

Myelofibrosis at diagnosis is associated with the failure of treatment-free remission in CML patients.

Journal: Frontiers in pharmacology

Published: April 26, 2023

XBP1 promotes NRASG12D pre-B acute lymphoblastic leukaemia through IL-7 receptor signalling and provides a therapeutic vulnerability for oncogenic RAS.

XBP1 promotes NRASG12D pre-B acute lymphoblastic leukaemia through IL-7 receptor signalling and provides a therapeutic vulnerability for oncogenic RAS.

Journal: Journal of cellular and molecular medicine

Published: April 13, 2023

Identification of Adult Patients With Classical Dyskeratosis Congenita or Cryptic Telomere Biology Disorder by Telomere Length Screening Using Age-modified Criteria.

Identification of Adult Patients With Classical Dyskeratosis Congenita or Cryptic Telomere Biology Disorder by Telomere Length Screening Using Age-modified Criteria.

Journal: HemaSphere

Published: September 12, 2022

Eltrombopag Preserves the Clonogenic Potential of Hematopoietic Stem Cells During Treatment With Antithymocyte Globulin in Patients With Aplastic Anemia.

Eltrombopag Preserves the Clonogenic Potential of Hematopoietic Stem Cells During Treatment With Antithymocyte Globulin in Patients With Aplastic Anemia.

Journal: HemaSphere

Published: August 29, 2022

Showing 1-12 of 31

Last Updated: 09/26/2026